CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...